Analyst firms · Chardan Capital Markets · KRRO
Chardan Capital Markets KRRO price target and rating history
Korro Bio Inc. (KRRO) · Health Care
Chardan Capital Markets rates Korro Bio Inc. (KRRO) Buy with a $15 price target, as of its latest action on Jan 29, 2026. It has published 3 rating actions on KRRO since April 2025, including 1 upgrade and 1 downgrade. Across 8 firms with a KRRO price target in the last 12 months, the median target is $21. Chardan Capital Markets's $15 is 29% below that.
- Current rating
- Buy
- Price target
- $15
- Median target, all firms
- $21
- Actions on KRRO
- 3
Chardan Capital Markets price target on KRRO
Every Chardan Capital Markets rating on KRRO
- Jan 29, 2026
- Nov 13, 2025
- Apr 16, 2025
How other firms rate KRRO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Buy | $21 | May 18, 2026 |
| Raymond James | Outperform | $23 | Mar 13, 2026 |
| William Blair | Outperform | Feb 17, 2026 | |
| Piper Sandler | Overweight | $30 | Jan 29, 2026 |
| Chardan Capital Markets | Buy | $15 | Jan 29, 2026 |
| H.C. Wainwright | Buy | $20 | Jan 29, 2026 |
| Cantor Fitzgerald | Overweight | $21 | Jan 28, 2026 |
| Oppenheimer | Outperform | $22 | Jan 28, 2026 |
| RBC Capital Markets | Sector Perform | $8 | Nov 13, 2025 |
Questions about Chardan Capital Markets and KRRO
- What is Chardan Capital Markets's price target for KRRO?
- Chardan Capital Markets's latest stated price target for Korro Bio Inc. (KRRO) is $15, from its action on Jan 29, 2026.
- What is Chardan Capital Markets's rating on KRRO?
- Chardan Capital Markets rates KRRO Buy, a bullish rating, as of Jan 29, 2026.
- When did Chardan Capital Markets last change its view on KRRO?
- On Jan 29, 2026, Chardan Capital Markets upgrades to Buy from Neutral, price target $15.
- How does Chardan Capital Markets's KRRO target compare with other analysts?
- Across 8 firms with a KRRO price target in the last 12 months, the median target is $21. Chardan Capital Markets's $15 is 29% below that.
More KRRO rating histories
All Chardan Capital Markets ratingsKRRO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.